NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Risynth Bio? Mail in a sample (US only) and let us test it.

Test my supply
69%
Finnrick rating
#304 of 457 ranked vendors
13 of 18 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Risynth Bio's purity-focus record is strongest on Tirzepatide, with clean identity, high-purity results and only modest fill variance, while Retatrutide and Semaglutide are more mixed. The misses are isolated purity shortfalls with some recovery signal, but evidence is thin, batch-clustered, and lightly corroborated, so consistency remains uncertain.

methodology →
vendor intelligence report
Vendor Intelligence Report: Risynth Bio

We investigated who actually operates Risynth Bio — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

23 pages8 risk factors assessed13 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
3
Semaglutide
$7.45
69%
4
4
Ipamorelin
$8.50
67%
3
5
BPC-157
$8.00
47%
3
6
GHK-Cu
$0.70
-
0
7
Tesamorelin
$15.00
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%1 Sep 2025: 63%1 Sep 2025: 66%1 Sep 2025: 69%1 Sep 2025: 69%1 Sep 2025: 68%4 Sep 2025: 67%4 Sep 2025: 61%4 Sep 2025: 61%4 Sep 2025: 62%4 Sep 2025: 62%4 Sep 2025: 63%4 Sep 2025: 63%4 Sep 2025: 63%4 Sep 2025: 64%9 Sep 2025: 63%2 Mar 2026: 63%2 Mar 2026: 65%2 Mar 2026: 66%7 Oct 2026: current 69%63%63%69%Sep 25Oct 26
Free peptide testing

Ordered peptides from Risynth Bio? Mail in a sample (US only) and let us test it.

Test my supply
Risynth Bio test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
2 Mar 2026
Fail
BPC-157
lab nameView COA
2 Mar 2026
Fail
Ipamorelin
lab nameView COA
2 Mar 2026
Pass
Semaglutide
lab nameView COA
9 Sep 2025
Fail
BPC-157
lab nameView COA
4 Sep 2025
Pass
Tirzepatide
lab nameView COA
4 Sep 2025
Pass
Tirzepatide
lab nameView COA
4 Sep 2025
Pass
Retatrutide
lab nameView COA
4 Sep 2025
Pass
Semaglutide
lab nameView COA
4 Sep 2025
Pass
BPC-157
lab nameView COA
4 Sep 2025
Pass
Ipamorelin
lab nameView COA
1-10 of 18

About Risynth Bio test results from Finnrick

Risynth Bio is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 18 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Risynth Bio peptides in this dataset are BPC-157 (3 tests), Ipamorelin (3 tests) and Retatrutide (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 18 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Risynth Bio? Mail in a sample (US only) and let us test it.

Test my supply